CMO Moves: Regulatory Catalysts for Drug Manufacturing-November
Pharmaceutical Technology analyzes recent regulatory decisions by several authorities that will likely impact therapy manufacturing plans.
Features
The “Medical Bypass”: new drugs to strike obesity
Expanding ketamine’s horizons to treat rare neurological disorders
Healthcare in 2030: smart toilets, robots and digitalisation
Magazine: What Rishi Sunak can do for the UK pharma industry
What do companies need from COP27?
Artificial intelligence hiring levels in the pharma industry dropped in October 2022
Internet of things hiring levels in the pharmaceutical industry dropped in October 2022
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
